DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Nugent D.
Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Thromb Res 2012;
130 (Suppl. 02) S12-S14
Access:
We do not assume any responsibility for the contents of the web pages of other providers.